Importantly, YKL-40, found by proteomic analysis of CSF samples, has been suggested as a useful biomarker for predicting disease progression from CIS to classical relapsing-remitting MS (RRMS) [31]. This evidence concerns the gene CHI3L1 and relapsing-remitting multiple sclerosis.